Mobile Cardiac Telemetry – MCOT patch vs implantable loop recorder
- By Philips
- March 03 2025
- 2 min read
This article highlights the cost benefits and predicted outcomes of using Philips Mobile Cardiac Telemetry – MCOT as first-line monitoring in post-cryptogenic stroke followed by an implantable loop recorder (ILR) vs ILR monitoring alone. The analysis demonstrates that an initial strategy of monitoring for 30 days with MCOT first-line for post-cryptogenic stroke can deliver significant cost savings compared to monitoring with ILR only and improves atrial fibrillation (AF) detection rates while reducing the risk of secondary stroke [1].
At-a-glance:
- MCOT as a first-line diagnostic detected 4.6 times more patients with AF compared to ILR only.
- MCOT followed by IRL resulted in almost 8 times lower costs compared to ILR alone, due to improved AF detection rates and reduction of secondary stroke risk [1].
- Total cost per patient with detected AF was significantly lower in the MCOT followed by ILR arm vs ILR only arm: $29,598 vs $228,507, respectively [1].
Taking part in daily activities while being monitored with Philips MCOT.
Use of MCOT first-line in post-cryptogenic stroke increases AF detection rates and lowers costs
This study was conducted in 1,000 adult patients diagnosed with having a cryptogenic stroke, without previously documented AF. Patients were assigned first to one then to the alternative monitoring strategies. The primary model outcome was the difference in total costs between the MCOT patch and ILR only arms for the whole cohort of 1,000 patients. Relevant secondary outcomes included: difference in costs per AF detected, average cost per one patient monitored, incremental recurrent strokes avoided and incremental infections avoided using MCOT patch vs ILR only arms.
The MCOT patch arm detected 4.6 times more patients with AF compared to the ILR alone arm (209 vs 45 patients with detected AF, respectively). MCOT patch followed by ILR leads to significant cost savings. Cost per patient with detected AF was significantly lower in the MCOT patch arm ($29,598) vs the ILR only arm ($228,507) [1].
This cost-minimization model demonstrates further support for the standard of care to be 30-day monitoring with MCOT post-cryptogenic stroke before an ILR is implanted. The improved AF detection rates of MCOT followed by ILR reduces the likelihood of a secondary stroke due to new anticoagulant use, resulting in a significantly lower total cost of care.
View the full study.
Copy this URLto share this story with your professional network
Footnotes
- Costs and event rates are based on a cohort of 1,000 patients and a time horizon of 1 year. https://pubmed.ncbi.nlm.nih.gov/34955658/
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.
Not available in all countries.